TG and neoplasm: Ciappuccini et al. [23] showed a significant correlation between the rhTSH-stimulated Tg levels measured immediately before RIT and persistent/recurrent disease (PRD), defined as evidence of tumor burden confirmed by histology or radiological modalities on follow-up.